Çağlagül Erol

Çağlagül Erol

Auto-generated profile, based on publicly available information

Çağlagül Erol

Beyhekim Training and Research Hospital

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2024 in Molecular Imaging and Radionuclide Therapy
Verified
Journal Article
Open access
ÇEÇağlagül Erol
Çağlagül Erol
ÖŞÖzlem Şahin
Özlem Şahin
AŞAhmet Eren Şen
Ahmet Eren Şen
ZAZeynep Aydın
Zeynep Aydın
Sagliker syndrome (SS) is a rare, exaggerated form of chronic kidney disease (CKD)-mineral and bone disorder resulting from untreated secondary hyperparathyroidism due to CKD. Herein, we describe a 34 -year -old male patient whose Tc-99m-methylene diphosphonate bone scintigraphy and Tc-99m-sestamibi parathyroid scintigraphy revealed hints of SS and exhibited its defining characteristics.

28 January 2026 in Cranio®
Verified
Journal Article
Closed access
SESeyit Erol
Seyit Erol
HÖHalil Özer
Halil Özer
AGAbdi Gürhan
Abdi Gürhan
MKMustafa Koplay
Mustafa Koplay
ÇEÇağlagül Erol
Çağlagül Erol
MOMehmet Ozturk
Mehmet Ozturk
To evaluate supervised machine learning (ML) models for classifying temporomandibular joint (TMJ) disc displacement on MRI using morphometric and signal intensity features. This retrospective study analyzed 324 TMJs from 162 individuals who underwent 3T MRI. Extracted features included condylar anteroposterior and mediolateral diameters, disc and condyle morphology, and lateral pterygoid muscle signal intensity ratios. Six ML algorithms (Random Forest, Gaussian Naïve Bayes, Logistic Regression, AdaBoost, Gradient Boost, and k-Nearest Neighbor) were evaluated using stratified 5-fold cross-validation. Performance was assessed with accuracy, macro-averaged recall, precision, F1-score, and ROC-AUC. All models demonstrated good classification performance (ROC-AUC >0.80). AdaBoost achieved the highest ROC-AUC (0.88), while Gaussian Naïve Bayes showed the most balanced overall metrics. Mediolateral condylar diameter and disc morphology were key features associated with disc displacement categories. ML models can identify MRI-based morphometric patterns related to TMJ disc displacement and may support radiologic assessment, while clinical diagnosis should continue to rely on established standards of care.

1 June 2022 in Molecular Imaging and Radionuclide Therapy
Verified
Journal Article
Open access
AŞAhmet Eren Şen
Ahmet Eren Şen
ÖŞÖzlem Şahin
Özlem Şahin
ZAZeynep Aydın
Zeynep Aydın
BKBuğra Kaya
Buğra Kaya
ÇEÇağlagül Erol
Çağlagül Erol
Pulmonary alveolar microlithiasis is a rare disease characterized by accumulating intraalveolar small calcium phosphate stones. The disease is slow and does not show any signs in the early stages, but the shortness of breath, cough, and right heart failure may develop as it progresses. Methylene diphosphonate used in bone scintigraphy shows high uptake of calcium deposits in the alveoli and causes diffuse increased radiopharmaceutical uptake in the lungs.

20 June 2025 in Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Verified
Journal Article
Closed access
ÇEÇ. Erol
Ç. Erol
ÖŞÖ. Şahin
Ö. Şahin
GKG. Kanyılmaz
G. Kanyılmaz
SES. Erol
S. Erol

31 August 2022 in Genel Tıp Dergisi
Verified
Journal Article
Closed access
PDF file
FYFarise Yilmaz
Farise Yilmaz
HÖHasan Önner
Hasan Önner
GGGonca Kara Gedi̇k
Gonca Kara Gedi̇k
ÖŞÖzlem Şahi̇n
Özlem Şahi̇n
AÇAhmet Volkan Çeli̇k
Ahmet Volkan Çeli̇k
ÇEÇağlagül Erol
Çağlagül Erol
Objective: Somatostatin analogs (SSA) are used in treating low-grade neuroendocrine tumors, mainly because of their antiproliferative effect. 68Ga tetraazacyclododecantetraacetic acid-DPhe1-Tyr3-octreotate (DOTATATE) PET/CT as somatostatin receptor imaging has been widely used in recent years. However, there are conflicting publications in the literature, although there are guidelines for discontinuing the use of SSA before imaging. This study aims to investigate the effect of SSAs on Somatostatin receptor imaging. Material and Method: We retrospectively analyzed 253 patients who underwent 68Ga-DOTATATE PET/CT imaging between 2018 and 2022. Among these patients, those with low grades (Grade 1 and Grade 2) using SSA were included in the study. SUVmax (maximum standard uptake volume) of normal target organs, primary tumors, and metastases with the highest SUVmax in each organ were compared before and after SSA treatment. Results: 28 patients (16 females; 12 males, age [mean±SD], 54.82±14.27, range 18-78) with low-grade (Grade 1 and 2) NET and 68Ga-DOTATATE PET/CT imaging with SSA therapy were included in the study. Although SUVmax was decreased in the values measured after SSA application in the liver and spleen, it was not statistically significant (p>0.05). There was no significant difference between SUVmax values in primary tumors and metastatic lesions in the liver, bone, lung, or lymph nodes before and after SSA application (P> 0.05). Conclusion: In conclusion, these drugs do not need to be discontinued before 68Ga-DOTATATE PET/CT imaging for treatment follow-up in neuroendocrine tumor patients using somatostatin analogs. In addition, these drugs may help report interpretation by increasing the intensity of metastatic lesions in the liver and spleen.